Elvucitabine Completed Phase 2 Trials for Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00675844An Open Label Treatment Protocol to Provide Continued Elvucitabine Treatment
NCT00350272Elvucitabine/Efavirenz/Tenofovir vs. Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects
NCT00405249Safety Study of Elvucitabine in HIV-1 Subjects